You are here

Justice News

Department of Justice
U.S. Attorney’s Office
Eastern District of Louisiana

FOR IMMEDIATE RELEASE
Monday, April 30, 2018

Local Doctor Arrested for Illegally Dispensing and Distributing Controlled Substances by Prescriptions

U.S. Attorney Duane A. Evans announced the unsealing of an indictment against WAYNE JEROME CELESTINE, age 57, a physician who practices in Gretna, Louisiana and resides in the New Orleans area.  On Monday, April 30, 2018, DR. CELESTINE was arrested on charges of distribution of controlled substances.  According to court records, DR. CELESTINE illegally dispensed and conspired with others to illegally dispense controlled substances, including oxycodone, oxycodone/acetaminophen, oxycontin HCL, oxymorphone HCL, hydromorphone, opana, fentanyl, suboxone, and morphine sulfate, a Schedule II drug controlled substances; hydrocodone/acetaminophen, a Schedule III drug controlled substance until October 6, 2014, thereafter, a Schedule II drug controlled substance; and alprazolam, diazepam, and carisoprodol, Schedule IV drug controlled substances.   

CELESTINE made his initial appearance before U.S. Magistrate Court Judge Daniel E. Knowles, III, on Monday, April 30, 2018.  A detention hearing is scheduled for May 1, 2018.

If convicted of the charge in the criminal complaint, CELESTINE will face a maximum of not more than 20 years in prison on the drug conspiracy charge, pursuant to Title 21, United States Code, Sections 841(a)(1) and 846.  CELESTINE will also be subject to a fine of not more than one million dollars and a minimum term of supervised release of three years, following any term of imprisonment.

U.S. Attorney Evans praised the work of the Special Agents of the Drug Enforcement Administration, Internal Revenue Service, Jefferson Parish Sheriff’s Office, Harahan Police Department, Westwego Police Department, Louisiana State Police, St. Bernard Parish Sheriff’s Office, New Orleans Police Department, and New Orleans District Attorney’s Office in investigating this matter.  Assistant United States Attorney John F. Murphy is in charge of the prosecution.

Topic(s): 
Opioids
Prescription Drugs
Updated May 1, 2018